We are pleased to introduce the following speakers at the 5th International Conference on Resveratrol and Health.

 

 

 

Dr. Nihal Ahmad

 

nahmad@dermatology.wisc.edu

 

Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA

 

Dr. Scott Boyer,

 

scott.boyer@klaria.com

 

Nutrinovate AB,

Sweden

Scott Boyer is currently Chief Executive Officer of Klaria AB, a Nasdaq-listed Drug Development Company based in Stockholm. Scott has also been Head of Computational Toxicology at the Swedish Toxicological Research Center at the Karolinska Institute, Sweden.  Prior to this he was Global Head of Molecular and Genetic Toxicology and Chief Scientist at AstraZeneca,  Principal Scientist at Pfizer.

Scott received his postdoctoral training in Molecular Toxicology at the Institute for Environmental Medicine, Karolinska Institute. Doctoral dissertation research was done in molecular toxicology at the University of Colorado in Boulder.

Scott Boyer has authored or co-authored over 100 peer-reviewed publications, over 300 published abstracts and six book chapters.

Dr. Karen Brown

 

kb20@leicester.ac.uk

 

Department of Cancer Studies, Leicester Royal Infirmary, University of Leicester, Leicester,

United Kingdom

 

Dr. Kuang Yu Chen

 

kychen@rutgers.edu

Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ, USA

 

Dr. Kuang Yu Chen obtained his Ph.D. in chemistry from Yale University, did post-doctoral work at Yale Medical School in pharmacology, became faculty member at Rutgers University. He is now Distinguished Professor of Chemistry and Chemical Biology at Rutgers. He is also an AAAS Fellow and Board of Director member of Confucius Institute at Ruters. His research focuses on hypusine/eIF-5A, polyamines, aging, and nutraceuticals. He is also interested in the application of chemistry in art and archaeology

Dr. J. Luis Espinoza

 

luis@med.kindai.ac.jp

 

Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University,

Osaka-Sayama, Osaka, Japan

 

 

Dr. Phillip M. Gerk,

 

pmgerk@vcu.edu

 

Virginia Commonwealth University, School of Pharmacy, Department of Pharmaceutics, Richmond, USA

 Dr. Phillip M. Gerk received his Doctor of Pharmacy (Pharm.D.) degree at the University of Illinois at Chicago, then did a clinical research fellowship at Auburn University.  He then attended the University of Kentucky where he received his Ph.D. and stayed to perform postdoctoral research.  He has been a faculty member at Virginia Commonwealth University in the Department of Pharmaceutics since 2004, where he performs his research on drug metabolism, transport, and oral bioavailability of antioxidants.

Dr. Hiroki Hamada,

 

hamada@dls.ous.ac.jp

 

Department of Life Sciences, Faculty of Science, Okayama University of Sciences, 1-1 Ridai-cho, Kita-ku, Okayama 700-0005, Japan

Professor, Department of Life Science, Faculty of Science, Okayama University of Science, Japan.


He received his Ph.D. degree from Hiroshima University in 1987. From 1988 to 1990, he worked as a postdoctoral fellow in Oklahoma State University and Texas A&M University.

 

In 1992, he was promoted to an assistant professor in Okayama University of Science and in 1998, he was appointed as a professor.
His current research involves development of novel biocatalysts including microbes, plants, and algae.

 

Recently, he is interested in glycosylation of biological active compounds using the living cells.

Dr. Azita Hekmatdoost

 

a_hekmat2000@yahoo.com

Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran

 

Dr. Marina K Holz

 

 

marina_holz@nymc.edu

 

New York Medical College; New York, NY, USA

Dr. Marina Holz is the Dean of the Graduate School of Basic Medical Sciences and Professor of Cell Biology and Anatomy at New York Medical College.

 

Dr. Holz received her Ph.D. in Cell and Developmental Biology at Harvard Medical School. Dr. Holz leads laboratory that studies the mechanisms of signaling by hormones and growth factors in breast cancer and lymphangioleiomyomatosis (LAM) — a rare lung disease.

 

Her work spans basic science and clinical applications.

Professor Peter Howe

 

peter.howe@newcastle.edu.au

 

School of Biomedical Sciences and Pharmacy, The University of Newcastle

Australia

Peter is Professor of Clinical Nutrition at the University of Southern Queensland, Emeritus Professor of Nutrition Research and convenor of the Clinical Nutrition Research Centre, University of Newcastle, Adjunct Professor at the University of South Australia and the University of Adelaide and Chair of TGA’s Advisory Committee for Complementary Medicines.

 

With a track record of preclinical and clinical research in nutrition, cardiovascular physiology and neuroscience, Peter is a recognised authority on health benefits of bioactive nutrients. He is Founding and Emeritus Editor of Nutrients and a Fellow of the Nutrition Society of Australia.

Dr. Yujie Huang

 

huangyujie2017@sina.com

 

Research Center of Nutrition and Food Safety, Chongqing Key Laboratory of Nutrition and Food Safety, Third Military Medical University, PR China

 

Dr. Yujie Huang is a Ph.D candidate. During the past five years, with the help of my kind tutor and colleagues, I have published some articles on some journals. Our research mainly focus on the effects of natural polyphenols on metabolic disorders and muscle atrophy. We also investigated the mechanisms responsible for the protective effects of natural polyphenols.

Dr. Anait S. Levenson

 

Anait.Levenson@liu.edu

 

Veterinary Medicine, Long Island University, Brookville, NY, USA

Dr. Anait S. Levenson is a Professor of Cancer Research and Pharmacology at the College of Veterinary Medicine, Long Island University, NY. Her scientific interest is in cancer research, specifically, in molecular mechanisms of hormone-dependent breast and prostate cancer. For the past several years, her laboratory has focused on understanding genetic and epigenetic mechanisms of prostate cancer progression and metastasis and on utilization of resveratrol and its analogs for MTA1-targeted prostate cancer chemoprevention and treatment.

Dr. Haishu Lin,

 

haishu.lin@nus.edu.sg

 

Department of Pharmacy, National University of Singapore, Singapore

Dr. Haishu Lin is an assistant professor from the Department of Pharmacy, National University of Singapore. During the past ten years, his research is well focused on the anti-inflammatory pharmacology, pharmacokinetics, metabolomics and drug delivery system of resveratrol and its dietary / herbal derivatives. Dr. Lin has ~ 50 publications in peer-reviewed journals and serves as an ad hoc reviewer for ~ 50 journals.
 

Dr. Qingyong Ma

 

qyma56@xjtu.edu.cn

 

Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an 710061, PR China
 

Dr. Fabricio Medina-Bolivar,

 

fmedinabolivar@astate.edu

 

Plant Metabolic Engineering

Department of Biological Sciences, Arkansas Biosciences Institute, Arkansas State University, AR 72467, USA

Dr. Fabricio Medina-Bolivar is a Professor of Metabolic Engineering at Arkansas State University.  He also serves as Executive Director of the American Council for Medicinally Active Plants and Chief Scientific Officer of Nature West Inc.

 

He has over 25 years of experience in plant biotechnology. Over the last years, his research has focused on bioproduction and biosynthesis of prenylated stilbenoids in hairy root cultures and assessing the biological activities of these compounds. His research led to the identification of the first stilbenoid-specific prenyltransferase involved in the prenylation of resveratrol.

 

Dr. Dragan Milenkovic,

 

dmilenkovic@ucdavis.edu

 

UC Davis School of Medicine, Department of Internal Medicine, Division of Cardiovascular Medicine, Genome and Biomedical Sciences Facility (GBSF)

Davis, CA 95616, USA
 Dr. Fabricio Medina-Bolivar is a Professor of Metabolic Engineering at Arkansas State University.  He also serves as Executive Director of the American Council for Medicinally Active Plants and Chief Scientific Officer of Nature West Inc. He has over 25 years of experience in plant biotechnology. Over the last years, his research has focused on bioproduction and biosynthesis of prenylated stilbenoids in hairy root cultures and assessing the biological activities of these compounds. His research led to the identification of the first stilbenoid-specific prenyltransferase involved in the prenylation of resveratrol.

Dr. Indraneel Mittra

 

indraneel.mittra@gmail.com

 

Department of Surgical Oncology, Tata Memorial Centre, Advanced Centre for Treatment, Research & Education in Cancer

Mumbai. India

Professor Indraneel (Neel) Mittra is Dr. Ernest Borges Chair in Translational Research, Advanced Centre for Treatment, Research & Education in Cancer, Tata Memorial Centre, Mumbai, India.

 

Professor Mittra obtained his medical degree from University of Delhi and is a Fellow of the Royal College of Surgeons of England and holds a PhD degree from University of London.  Professor Mittra’s current research interests lie in the area of biology of extracellular nucleic acids and their role in ageing, inflammation, degenerative disorders and cancer.

 

Dr. Thomas Netticadan

 

TNetticadan@sbrc.ca

 

Heart Failure Research Laboratory, Canadian Centre for Agri-Food Research in Health and Medicine, St. Boniface Research Centre, Winnipeg, MB, Canada
 

Dr. Coral Sanfeliu Pujol

 

coral.sanfeliu@iibb.csic.es

 

Department  of  Brain  Ischemia  and Neurodegeneration, Institut d’Investigacions Biomèd

iques de Barcelona (IIBB), CSIC-IDIBAPS, Barcelona, Spain

Dr. Coral Sanfeliu is a neuroscientist at the Institute of Biomedical Research of Barcelona (IIBB) of the Spanish research council (CSIC), and also joins IDIBAPS, CIBERESP and European COST networks.

 

She heads the Aging and Neurodegeneration Lab focused in molecular alterations that lead to dementia and in preventive strategies. They are currently investigating endogenous neuroprotective mechanisms induced by resveratrol in experimental models.

 

Dr. Sergio Riva,

 

sergio.riva@icrm.cnr.it

Istituto di Chimica del Riconoscimento Molecolare, C.N.R. Italy

Dr. Sergio Riva is presently the Director of the Institute of the Chemistry of Molecular Recognition  of the Italian National Council of Research (C.N.R.), where he has been working since 1984, and “Professore a Contratto” at the University of Modena and Reggio Emilia since 2000.

He took his Laurea in Chemistry at Milano University in 1983 and his Diploma di Specialità in Organic Synthesis at Milano Politecnico in 1989. He spent one year (1987) at M.I.T. (USA) working with Prof. A. Klibanov.

His scientific activity is documented by more than 200 publications reporting on the isolation and characterization of different groups of enzymes and on their synthetic exploitation

 


Dr. Jeff A. Stuart

 

jstuart@brocku.ca

 

Department of Biological Sciences and Cold Climate Oenology and Viticulture Institute, Brock University, St. Catharines, ON L2S 3A1, Canada

Dr. Jeff Stuart received his PhD from the University of Guelph, Canada, followed by postdoctoral research in the Biochemistry Department at the University of Cambridge and at the National Institute on Aging (NIH). 

 

He has been a faculty member at Brock University, Canada, in the Department of Biological Sciences since 2004 and a research fellow at the Cold Climate Oenology and Viticulture Institute at Brock since 2010.  Dr. Stuart’s resveratrol research focuses on its modulation of mitochondrial and cellular functions, including reactive oxygen species metabolism and mitochondrial dynamics.


Dr. Jianbo Xiao,

 

jianboxiao@yahoo.com

 

Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau, PR China.
 

 

Dr. Dianzheng Zhang

 

dianzhengzh@pcom.edu

 

Department of Bio-Medical Sciences and Center for Chronic Diseases of Aging, Philadelphia College of Osteopathic Medicine, PA 19131, Philadelphia, USA

 

 

Hold a Ph.D. degree in Nutritional Sciences (University of Arizona). Engaging in research with nutrients/ natural products and cancer thereafter. Focusing on the roles of resveratrol in prostate cancerDeciphering regulating roles of resveratrol on androgen receptor (AR) and AR variants.

 


The conference language is English, but there will be simultaneous translation: Chinese to English and English to Chinese.
 

Resveratrol2018 - resveratrolconference@gmail.com

International Academic Center, Third Floor of Science and Education Building,

The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Rd, Xi’an, Shaanxi, China.